KRAS G12C inhibitor 13
KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30[1].
Product Specifications
CAS Number
2241719-75-3
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-13.html
Solubility
10 mM in DMSO
Smiles
C=CC(C(C1=C(C=NN2)C2=CC=C1C)=C3OCC(F)(F)F)=CC4=C3N=C(OC5CCN(C6CCOCC6)CC5)N=C4N7CCC8(CN(C(C=C)=O)C8)CC7
Molecular Formula
C40H46F3N7O4
Molecular Weight
745.83
References & Citations
[1]KURAMOTO, Kazuyuki, et al. Quinazoline compound. WO2018143315A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470040-500 1x 500 µL
CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940096-100 1x 100 µL
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
